Literature DB >> 26623079

Treatment of coronary in-stent restenosis-evidence for universal recommendation?

Ibrahim Akin1, Christoph A Nienaber1.   

Abstract

Year:  2015        PMID： 26623079      PMCID： PMC4635288          DOI： 10.3978/j.issn.2072-1439.2015.10.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

1.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  J Am Coll Cardiol       Date:  2011-11-07       Impact factor: 24.094

2.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

3.  Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty.

Authors:  R A Hernández; C Macaya; A Iñiguez; F Alfonso; J Goicolea; A Fernandez-Ortiz; P Zarco
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

4.  Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]).

Authors:  Fernando Alfonso; Maria J Pérez-Vizcayno; Jaime Dutary; Javier Zueco; Angel Cequier; Arturo García-Touchard; Vicens Martí; Iñigo Lozano; Juan Angel; José M Hernández; José R López-Mínguez; Rafael Melgares; Raúl Moreno; Bernhard Seidelberger; Cristina Fernández; Rosana Hernandez
Journal:  JACC Cardiovasc Interv       Date:  2012-07       Impact factor: 11.195

5.  Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.

Authors:  Joo Myung Lee; Jonghanne Park; Jeehoon Kang; Ki-Hyun Jeon; Ji-Hyun Jung; Sang Eun Lee; Jung-Kyu Han; Hack-Lyoung Kim; Han-Mo Yang; Kyung Woo Park; Hyun-Jae Kang; Bon-Kwon Koo; Hyo-Soo Kim
Journal:  JACC Cardiovasc Interv       Date:  2015-02-18       Impact factor: 11.195

Review 6.  In-stent restenosis in the drug-eluting stent era.

Authors:  George D Dangas; Bimmer E Claessen; Adriano Caixeta; Elias A Sanidas; Gary S Mintz; Roxana Mehran
Journal:  J Am Coll Cardiol       Date:  2010-11-30       Impact factor: 24.094

7.  Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

Authors:  Gregg W Stone; Jeffrey W Moses; Stephen G Ellis; Joachim Schofer; Keith D Dawkins; Marie-Claude Morice; Antonio Colombo; Erick Schampaert; Eberhard Grube; Ajay J Kirtane; Donald E Cutlip; Martin Fahy; Stuart J Pocock; Roxana Mehran; Martin B Leon
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

8.  Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.

Authors:  David R Holmes; Paul Teirstein; Lowell Satler; Michael Sketch; James O'Malley; Jeffery J Popma; Richard E Kuntz; Peter J Fitzgerald; Hong Wang; Eileen Caramanica; Sidney A Cohen
Journal:  JAMA       Date:  2006-03-12       Impact factor: 56.272

9.  Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.

Authors:  M A Thornton; A R Gruentzig; J Hollman; S B King; J S Douglas
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

10.  Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.

Authors:  Salvatore Cassese; Robert A Byrne; Tomohisa Tada; Susanne Pinieck; Michael Joner; Tareq Ibrahim; Lamin A King; Massimiliano Fusaro; Karl-Ludwig Laugwitz; Adnan Kastrati
Journal:  Heart       Date:  2013-11-22       Impact factor: 5.994
View more
  3 in total

1.  Treatment for in-stent restenosis: patient-specific decision rather than universal recommendation.

Authors:  Joo Myung Lee; Jonghanne Park; Tae-Min Rhee; Hyo-Soo Kim
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

2.  Effects of captopril and valsartan on ventricular remodeling and inflammatory cytokines after interventional therapy for AMI.

Authors:  Xiaona Gong; Raorao Zhou; Qinhao Li
Journal:  Exp Ther Med       Date:  2018-08-20       Impact factor: 2.447

3.  Effects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1 after PCI of acute myocardial infarction.

Authors:  Yuqing Zhang; Tingguo Shao; Lei Yao; Hong Yue; Zhiyu Zhang
Journal:  Exp Ther Med       Date:  2018-08-08       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.